Takahiro Takazono
Overview
Explore the profile of Takahiro Takazono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
181
Citations
993
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Tokito T, Kido T, Sato S, Tashiro M, Miyashita R, Ozasa M, et al.
Respir Med
. 2024 Oct;
234:107834.
PMID: 39395617
Background: Azithromycin has favorable effects on critical respiratory diseases owing to its antimicrobial and anti-inflammatory properties. During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, azithromycin was frequently...
22.
Iwanaga N, Ota A, Ashizawa H, Ito Y, Hirayama T, Yoshida M, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39335081
In the present study, we aimed to clarify the mechanisms by which periodontal pathogens, particularly , induce severe neutrophilic inflammation. In addition, we aimed to test the efficacy of macrolides,...
23.
Takazono T, Fujita S, Komeda T, Miyazawa S, Yoshida Y, Kitanishi Y, et al.
Infect Dis Ther
. 2024 Sep;
13(11):2463-2467.
PMID: 39331323
No abstract available.
24.
Takeda K, Takazono T, Mukae H
Front Microbiol
. 2024 Sep;
15:1468383.
PMID: 39301186
Non-tuberculous mycobacterial pulmonary disease (NTM-PD) is a refractory chronic respiratory infectious disease and its prevalence is increasing globally. The standard treatment regimen for NTM-PD involves long-term multidrug therapy including macrolides....
25.
Ashizawa N, Takazono T, Ota K, Ito Y, Hirayama T, Takeda K, et al.
J Infect Chemother
. 2024 Aug;
31(1):102504.
PMID: 39197666
Introduction: The diagnostic tools of nucleic acid amplification tests and antigen tests have been extensively employed for the detection of Coronavirus disease 2019 (COVID-19). Although the reverse-transcriptase polymerase chain reaction...
26.
Takazono T, Ito G, Hosogaya N, Iwanaga N, Komeda T, Kobayashi M, et al.
Influenza Other Respir Viruses
. 2024 Aug;
18(9):e70002.
PMID: 39189087
This retrospective cohort study analyzed data from a Japanese health insurance database to assess the effectiveness of baloxavir (n = 4822) for preventing severe events compared with oseltamivir (n = ...
27.
Umeyama Y, Soda H, Senju H, Ogata R, Iwanaga M, Hayashi H, et al.
Case Rep Oncol
. 2024 Aug;
17(1):865-873.
PMID: 39144244
Introduction: This case report presents the successful detection of an exon 19 deletion using virtual bronchoscopic navigation (VBN) and endobronchial ultrasound with guide sheath (EBUS-GS) brushing, integrated with highly sensitive...
28.
Kitamura M, Yamashita H, Sugiyama S, Kuroki R, Fukuda H, Sawase A, et al.
Ther Apher Dial
. 2024 Jul;
28(6):931-940.
PMID: 38946143
Introduction: Functional decline occurs during dialysis initiation, particularly in unplanned cases. To prevent unplanned hemodialysis, we aimed to identify associated factors from the first referral to the nephrology department to...
29.
Takazono T, Fujita S, Komeda T, Miyazawa S, Yoshida Y, Kitanishi Y, et al.
Infect Dis Ther
. 2024 Jun;
13(8):1821-1833.
PMID: 38941067
Introduction: This study aimed to evaluate the effectiveness of ensitrelvir, an oral antiviral, in reducing hospitalization risk in outpatients at high-risk for severe COVID-19 during the Omicron era. Methods: This...
30.
Tashiro M, Takazono T, Izumikawa K
Ther Adv Infect Dis
. 2024 Jun;
11:20499361241253751.
PMID: 38899061
Chronic pulmonary aspergillosis (CPA) is a challenging respiratory infection caused by the environmental fungus . CPA has a poor prognosis, with reported 1-year mortality rates ranging from 7% to 32%...